Close
CDMO Safety Testing 2026
Novotech

Production & Manufacturing

Sustainable Nutraceutical Ingredients Shaping the Future

The Shift Toward Sustainable Ingredients One of the most significant transformations in the nutraceutical sector is the shift towardย eco-friendly and responsibly sourced ingredients. Marine-Based Nutraceuticals Marine-derived ingredients such as seaweed, algae, and bioactive compounds are gaining traction due to their high efficacy...

High-Purity Ingredients: The New Benchmark in Nutraceuticals

In todayโ€™s competitive nutraceutical market, quality is no longer optionalโ€”it is essential. Consumers, regulators, and healthcare professionals are increasingly demanding products that deliver consistent results backed by science. As a result, high-purity ingredients are emerging as the new benchmark...

Why Integrated CDMO Partnerships Replace Multi-Vendor Models

Key Takeaways: The multi-vendor model in biopharma CMC creates communication risk, timeline gaps, and regulatory complexity Integrated CDMO partnerships consolidate development and manufacturing under a single organization with end-to-end knowledge of the process Single-partner models improve technology transfer efficiency...

Neuland Laboratories Expands Peptide Manufacturing Capacity

Neuland Laboratories is preparing to launch a new commercial peptide manufacturing facility at its 17-acre Bonthapally manufacturing campus, with the first phase expected to become operational in the summer of this year. The project forms part of a broader...

Regulatory Roadmap Set for UK Space-Based Drug Manufacturing

The UK government and national regulators have introduced a coordinated regulatory roadmap aimed at enabling space-based drug manufacturing, marking a significant step toward commercialising drug production in microgravity environments. The initiative brings together the UK Space Agency, the Medicines...

Taiwan Launches $755M Pharma Resilience Plan to Boost Supply

Taiwan is preparing a four-year national pharmaceutical resilience preparedness program designed to strengthen its domestic drug supply, supported by a 24 billion new Taiwan dollar ($755 million) investment. The initiative is intended to reinforce the countryโ€™s ability to maintain...

Norgine Invests ยฃ23m to Expand Hengoed Pharma Facility in UK

Norgine has confirmed a ยฃ23 million ($31 million) investment in its manufacturing facility in Hengoed, Wales, increasing the total capital directed toward the site to more than ยฃ50 million ($67 million) since 2022. The move is intended to strengthen...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป